Recently, treatment with recombinant TNF-α in the presence of IFN-γ was found to enhance mycobacterial killing (Herbst et al., 2011), whereas defects in TNF-α or its receptor were found to promote M. tuberculosis replication and progressive lung disease in M. tuberculosis-infected mice (Mohan et al., 2001). Here, TNF is linked to lung disorder.